Modelling HIV and MTB Co-Infection Including Combined Treatment Strategies
Open Access
- 28 November 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (11) , e49492
Abstract
A new host-pathogen model is described that simulates HIV-MTB co-infection and treatment, with the objective of testing treatment strategies. The model includes CD4+ and CD8+ T cells, resting and activated macrophages, HIV and Mycobacterium tuberculosis (MTB). For TB presentation at various stages of HIV disease in a co-infected individual, combined treatment strategies were tested with different relative timings of treatment for each infection. The stages were early HIV disease, late HIV disease and AIDS. The main strategies were TB treatment followed by anti-retroviral therapy (ART) after delays of 15 days, 2 months and 6 months. ART followed by TB treatment was an additional strategy that was tested. Treatment was simulated with and without drug interaction. Simulation results were that TB treatment first followed by ART after a stage-dependent delay has the best outcome. During early HIV disease a 6 month delay is acceptable. During late HIV disease, a 2 month delay is best. During AIDS it is better to start ART after 15 days. However, drug interaction works against the benefits of early ART. These results agree with expert reviews and clinical trials.Keywords
This publication has 50 references indexed in Scilit:
- Integration of Antiretroviral Therapy with Tuberculosis TreatmentNew England Journal of Medicine, 2011
- Timing of Antiretroviral Therapy for HIV-1 Infection and TuberculosisNew England Journal of Medicine, 2011
- A multifaceted approach to modeling the immune response in tuberculosisWIREs Mechanisms of Disease, 2010
- Timing of Antiretroviral Therapy for HIV in the Setting of TB TreatmentJournal of Immunology Research, 2010
- Timing of Initiation of Antiretroviral Drugs during Tuberculosis TherapyNew England Journal of Medicine, 2010
- Modeling the immune rheostat of macrophages in the lung in response to infectionProceedings of the National Academy of Sciences, 2009
- Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycleProceedings of the National Academy of Sciences, 2008
- Modelling the Human Immune System by Combining Bioinformatics and Systems Biology ApproachesJournal of Biological Physics, 2006
- CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause?Nature Medicine, 2002
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996